Jan C.C. Borleffs - Concepedia

Author

Jan C.C. Borleffs

Also Known As

J C Borleffs, J C C Borleffs, J. C. Borleffs, J. C. C. BORLEFFS, J. C. C. Borleffs, J.C Borleffs, J.C. Borleffs, J.C.C. Borleffs, J. C. C. Borleffs, JAN C. C. BORLEFFS

136

Publications

4.7K

Citations

H-Index

Concepts

All Affiliations

Utrecht University University Medical Center Utrecht University of Groningen University Medical Center Groningen Amsterdam UMC Location University of Amsterdam

About

Jan C.C. Borleffs is an author at Utrecht University specializing in medicine, hiv, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	16	1K
2	Public Health	4	4	53
3	Education	2	2	30
4	Language Studies	1	1	34
5	Nursing	1	1	12

Jan C.C. Borleffs

Publications

4.1K

Citations

H-Index

Page 1

	Year	Citations
A Short-Term Study of the Safety, Pharmacokinetics, and Efficacy of Ritonavir, an Inhibitor of HIV-1 Protease Sven A. Danner, Andrew Carr, John M. Leonard, New England Journal of Medicine	1995	569
T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART) Mette D. Hazenberg, J. W. T. Cohen Stuart, Sigrid A. Otto, Blood	2000	442
Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection Mette D. Hazenberg, Sigrid A. Otto, J. W. T. Cohen Stuart, Nature Medicine Cell DivisionHuman RetrovirusT-regulatory CellImmunologyThymic Dysfunction	2000	395
Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis Alexander C. A. P. Leenders, Peter Reiss, Peter Portegies, AIDS	1997	287
A Controlled Trial of Aerosolized Pentamidine or Trimethoprim–Sulfamethoxazole as Primary Prophylaxis against<i>Pneumocystis carinii</i>Pneumonia in Patients with Human Immunodeficiency Virus Infection M. M. E. Schneider, Andy I. M. Hoepelman, Jan Karel M. Eeftinck Schattenkerk, New England Journal of Medicine	1992	278
Discontinuation of prophylaxis for Pneumocystis carinii pneumonia in HIV-1-infected patients treated with highly active antiretroviral therapy M. M. E. Schneider, Jan C.C. Borleffs, Ronald P. Stolk, The Lancet Treatment And PreventionActive Antiretroviral TherapyPneumocystis Carinii PneumoniaHivClinical Infectious Disease	1999	185
Activation and Cell Cycle Antigens in CD4<sup><b>+</b></sup>and CD8<sup><b>+</b></sup>T Cells Correlate with Plasma Human Immunodeficiency Virus (HIV‐1) RNA Level in HIV‐1 Infection Jurgen M. Orendi, Andries C. Bloem, Jan C.C. Borleffs, The Journal of Infectious Diseases Immune RegulationImmunologyImmunodominanceCell Cycle AntigensCd4 T Cell Responses	1998	120
Specialty preferences: Trends and perceptions among Saudi undergraduate medical students Syed Imran Mehmood, Ashish Kumar, Ali M Al-Binali, Medical Teacher	2012	110
Implementation of simulation in surgical practice: Minimally invasive surgery has taken the lead: The Dutch experience Henk W.R. Schreuder, S. Guid Oei, Mario Maas, Medical Teacher	2011	100
Vertical integration in medical school: effect on the transition to postgraduate training Marjo Wijnen‐Meijer, Olle ten Cate, Marieke van der Schaaf, Medical Education	2010	97

Page 1